Table A1.
Associations between count of adverse events in childhood and CRP (mg/L) and IL-6 (pg/mL) at 10 years and CRP (mg/L) at 15 years.a
Timing of adverse events | Age 10 Log CRPb
|
Age 10 Log IL-6b
|
||||
---|---|---|---|---|---|---|
β | SE | p-value | β | SE | p-value | |
1.5 years | 0.02 | (0.03) | 0.64 | −0.01 | (0.02) | 0.80 |
2.5 years | 0.02 | (0.03) | 0.47 | 0.01 | (0.02) | 0.66 |
3.5 years | 0.02 | (0.03) | 0.50 | 0.00 | (0.02) | 0.84 |
4.5 years | 0.01 | (0.04) | 0.75 | 0.01 | (0.03) | 0.72 |
6 years | 0.05 | (0.04) | 0.21 | 0.04 | (0.03) | 0.21 |
7 years | 0.10 | (0.05) | 0.03 | 0.15 | (0.03) | <.0001 |
8 years | 0.10 | (0.04) | 0.03 | 0.11 | (0.03) | 0.001 |
Sum scorec | 0.03 | (0.01) | 0.02 | 0.01 | (0.01) | 0.10 |
Age 15 Log CRP d
|
Age 15 Log CRP adjusted for Age10 CRP d
|
|||||
---|---|---|---|---|---|---|
β | SE | p-value | β | SE | p-value | |
1.5 years | 0.10 | (0.04) | 0.01 | 0.07 | (0.04) | 0.09 |
2.5 years | 0.02 | (0.04) | 0.55 | 0.03 | (0.04) | 0.47 |
3.5 years | 0.06 | (0.04) | 0.11 | 0.06 | (0.04) | 0.17 |
4.5 years | 0.04 | (0.04) | 0.36 | 0.03 | (0.05) | 0.54 |
6 years | −0.05 | (0.04) | 0.19 | −0.09 | (0.05) | 0.06 |
7 years | 0.02 | (0.05) | 0.66 | −0.01 | (0.06) | 0.90 |
8 years | 0.10 | (0.05) | 0.04 | 0.13 | (0.06) | 0.02 |
Sum scorec | 0.02 | (0.01) | 0.13 | 0.02 | (0.01) | 0.18 |
Note: In the models not adjusted for age 10 CRP, the sample sizes in the baseline models range from N = 2802 (for the model of adverse events at 1.5 years) to N = 2047 (for the model using the summary score). In models adjusted for age 10 CRP, the samples sizes in the baseline models range from N = 1888 (model of adverse events at 1.5 years) to N = 1427 (model using the summary score).
Linear regression coefficients; models adjusted for gender, age at blood collection, ethnicity, family income at age 8 (5 categories + missing category), mother’s education at gestation (4-categories + missing category), medication at blood collection. Coefficients estimated in separate models.
For the age 10 outcomes, the sample sizes in the baseline models range from N = 4126 (for the model of adverse events at 1.5 years) to N = 2895 (for the model using the summary score which requires data from all 7 time points).
Sum of adverse events, collapsing measures between 1.5 and 8 years.